It has been found from a new analysis that was conducted by the Swedish National Prostate Cancer Register, which stated that all men who are suffering from prostate cancer are at a greater risk of developing thromboembolic disease, whereas other people do not run that high tendency to suffer from this disease.
A report released this week offers some serious data on worldwide maternal and infant death rates.
It was found that roughly 350,000 to 500,000 women still die in childbirth every year, while 3.6 million newborns die in the first month of life. Another 5.2 million children succumb to death before the age of 5 years.
On Thursday, Celgene Corp stated that it will pay $130 million for the alternative to develop and sell cancer medicines discovered by secretly held Agios Pharmaceuticals Inc.
At the summit, New Jersey-based Celgene, which produces the blood cancer medicines such as Thalomid and Revlimid said that the imbursement will consist of an undisclosed equity stake in Agios.